It can be speculated that Nef acts predominantly in the elimination of nascent MHC-I molecules, and not on the ones already expressed on the cell surface, because only the newly synthesized molecules would harbor viral antigens, while the ones already present on the cell-surface prior to infection wouldn’t trigger an anti-HIV CTLs response and rather inhibit NK activation. The gene discussed is S100B; the disease is infection.